ArticleArchives of toxicology2026
Defining early carcinogenic markers for the prediction of the hazard potential of mineral fibres in an in vitro human 3D bronchial model.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify early carcinogenic markers to predict the hazard potential of mineral fibres using a human 3D bronchial model. Traditional 2D cell models inadequately mimic lung complexity, prompting the use of more physiologically relevant 3D systems. We investigated the effects of crocidolite (CRO) and two size fractions of chrysotile (≤ and > 5 μm length: CHR S and CHR L) to elucidate early toxicological mechanisms and relate them to the IARC key characteristics (KCs) of carcinogens. Initial analyses (MTT, TEER, and histology) at 24-48 h showed a transient acute toxicity and tissue resilience, indicating limited predictive value at this time point. However, after 12 d of exposure, fibre-treated tissues exhibited persistent alterations corresponding to established IARC KCs, suggesting the early onset of cell transformation pathways. Key findings included: sustained inflammatory signalling, characterized by prolonged overexpression of IL-1β, IL-6, and IL-8; ii) persistent genotoxicity, marked by the prolonged nuclear positivity of γH2AX, indicating DNA double-strand breaks without significant cell death; and iii) induction of fibrotic and epithelial-to-mesenchymal transition (EMT) signals, including the increased expression of key markers such as TGF-β, VEGF, ZEB-2, N-Cadherin, Vimentin, and Mesothelin. These alterations correspond to IARC KCs 2, 6, and 8. They were observed within a short time frame of tissue treatment and could serve as reliable, early predictive endpoints for in vitro toxicological tests. We propose that integrating these specific KC-based biosignatures in 3D lung models with physicochemical fibre characterization may provide a robust framework for predictive assessment of inhalable fibre carcinogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.